Currently, limited clinical cancer-specific data are available and information is evolving. However, ASCO has published FAQs with evidence-based inputs provided by clinical oncologists and infectious disease experts.

Here we have collated frequently asked questions that ASCO has put together in an attempt to help provide guidance to oncology professionals in their approach as they deal with the impact of coronavirus on their patients and staff.

For the original document on ASCO click here. 

For live coverage and more updates on COVID-19 click here.